Science ❯Biotechnology

Drug Development

Clinical Trials Oncology Cancer Research Clinical Research Therapeutic Innovations Cancer Therapies Therapeutic Candidates Biomacromolecules Integrated Stress Response Manufacturing Lifespan Extension Autoimmune Conditions ANAVEX®2-73 Mechanism of Action Clinical Studies Biosimilars Formulation Science Analytical Techniques Phase 2 Studies Nanoparticle Formulation Research and Development Smart Insulin Non-Pharmaceutical Interventions

Agg-CLNP Nanotherapy Delays Rheumatoid Arthritis Onset and Tames Flares in Preclinical Models

Researchers are preparing to refine formulations and assess toxicity ahead of first-in-human studies

Agilent Technologies Launches Operational Biopharma Experience Centre in Hyderabad

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research

Weekly Parkinson’s Injection Secures Patent After Successful Lab Trials

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

Dr. Reddy’s and Alvotech Partner to Develop Global Keytruda Biosimilar

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Sanofi to Acquire Vigil Neuroscience in $600M Deal to Advance Alzheimer’s Research

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

GSK Acquires US Biotech IDRx in $1.15 Billion Deal to Advance Rare Cancer Treatment

Breakthrough Drug Delivery System Crosses Blood-Brain Barrier

BioNTech Acquires China's Biotheus for $800 Million to Enhance Cancer Drug Development

Biontech's Revenue Surges with Updated Covid-19 Vaccine

New Nasal Spray Shows Promise in Blocking Multiple Respiratory Viruses

Moderna to Cut $1.1 Billion in R&D Spending as Vaccine Sales Decline

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial

Researchers Develop 'Smart Insulin' for Improved Diabetes Management

Biogen Acquires HI-Bio for $1.15 Billion to Enhance Immunology Pipeline